Inflammatory bowel disease - Environmental modification and genetic determinants

被引:11
|
作者
Kupthasan, Subra
Amre, Devendra
机构
[1] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[2] Univ Montreal, Hop St Justine, Res Ctr, Dept Pediat, Montreal, PQ H3T 1C5, Canada
关键词
D O I
10.1016/j.pcl.2006.05.009
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Inflammatory bowel disease (IBD) is a complex disease, controlled by multiple risk factors that evolve and interact together. In a genetically susceptible host, there are multiple processing steps controlled by the host and the environment, from environmental exposure to the clinical and biological expression of IBD-related phenotypes. This article discusses the recent genetic discoveries, along with the proposed environmental risk factors that have been implicated in IBD. Technical advances of the HapMap project and the promise of whole genome association scans have given hopes for clarifying gene-environmental interactions in IBD that ultimately lead to a clearer understanding of the pathogenesis.
引用
收藏
页码:727 / +
页数:24
相关论文
共 50 条
  • [31] The genetic jigsaw of inflammatory bowel disease
    Watts, DA
    Satsangi, J
    GUT, 2002, 50 : 31 - 36
  • [32] Genetic advances in inflammatory bowel disease
    Cho J.
    Current Treatment Options in Gastroenterology, 2006, 9 (3) : 191 - 200
  • [33] Genetic susceptibility in inflammatory bowel disease
    Yamamoto-Furusho J.K.
    Clinical Reviews in Bone and Mineral Metabolism, 2010, 8 (3): : 149 - 159
  • [34] Modification of enteral diets in inflammatory bowel disease
    Aldhous, MC
    Meister, D
    Ghosh, S
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (04) : 457 - 461
  • [35] Molecular/genetic determinants of repolarization and their modification by environmental stress
    Rosen, MR
    Cohen, IS
    JOURNAL OF INTERNAL MEDICINE, 2006, 259 (01) : 7 - 23
  • [36] Challenges Associated with Identifying the Environmental Determinants of the Inflammatory Bowel Diseases
    Molodecky, Natalie A.
    Panaccione, Remo
    Ghosh, Subrata
    Barkema, Herman W.
    Kaplan, Gilaad G.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (08) : 1792 - 1799
  • [37] Moving towards disease modification in inflammatory bowel disease therapy
    Allen, Patrick B.
    Peyrin-Biroulet, Laurent
    CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (04) : 397 - 404
  • [38] Determinants of Quality of Life in Patients with Inflammatory Bowel Disease
    Hewett, Jennifer
    Deconda, Deepthi
    Proctor, Deborah
    Zhang, Clarence
    Esposito, Christal
    Cho, Judy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S457 - S458
  • [39] Faecal metabolome and its determinants in inflammatory bowel disease
    Vila, Arnau Vich
    Hu, Shixian
    Andreu-Sanchez, Sergio
    Collij, Valerie
    Jansen, Bernadien H.
    Augustijn, Hannah E.
    Bolte, Laura A.
    Ruigrok, Renate A. A. A.
    Abu-Ali, Galeb
    Giallourakis, Cosmas
    Schneider, Jessica
    Parkinson, John
    Al-Garawi, Amal
    Zhernakova, Alexandra
    Gacesa, Ranko
    Fu, Jingyuan
    Weersma, Rinse K.
    GUT, 2023, 72 (08) : 1472 - 1485
  • [40] Determinants of job stress in patients with inflammatory bowel disease
    Schreiner, P.
    Biedermann, L.
    Rossel, J. -B.
    Pittet, V.
    von Kanel, R.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S464 - S464